Connection

Helmut Albrecht to Lamivudine

This is a "connection" page, showing publications Helmut Albrecht has written about Lamivudine.
Connection Strength

0.049
  1. Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial. Lancet Infect Dis. 2013 Nov; 13(11):927-35.
    View in: PubMed
    Score: 0.028
  2. Serial knife stabbings with HIV exposure--implications for post-exposure prophylaxis. J Infect. 2010 Jan; 60(1):76-8.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.